![Ulrich Dauer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ulrich Dauer
Directeur/Bestuurslid bij
Atriva Therapeutics GmbH
Profiel
Ulrich Dauer was the founder of 4SC AG, where he held the title of Chief Executive Officer from 1997 to 2013.
He is currently a Non-Executive Director at Atriva Therapeutics GmbH.
Dr. Dauer's former positions include Chief Executive Officer at OMEICOS Therapeutics GmbH and Ventaleon GmbH, and Chief Strategy Officer at Vectura GmbH.
He was also the Chief Executive & Financial Officer at Vivoryon Therapeutics NV from 2018 to 2021.
Dr. Dauer obtained a doctorate degree from Julius-Maximilians-Universität Würzburg.
Actieve functies van Ulrich Dauer
| Bedrijven | Functie | Begin |
|---|---|---|
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Directeur/Bestuurslid | - |
Eerdere bekende functies van Ulrich Dauer
| Bedrijven | Functie | Einde |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Algemeen Directeur | 14-08-2023 |
| 4SC AG | Algemeen Directeur | 31-03-2013 |
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation | Algemeen Directeur | - |
OMEICOS Therapeutics GmbH
 OMEICOS Therapeutics GmbH BiotechnologyHealth Technology Develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation | Algemeen Directeur | - |
Vectura GmbH
 Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Corporate Officer/Principal | - |
Opleiding van Ulrich Dauer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
28
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Vectura GmbH
Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Commercial Services |
Julius-Maximilians-Universität Würzburg
 Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology Develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation | Health Technology |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation | Health Technology |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Health Technology |
